MedPacto메드팩토
235980 · KOSDAQ · ₩235980 · 메드팩토
₩3,050▲ ₩80 (2.69%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 8.3% | 9.9% | — | — | — | — |
| Operating margin | −309.6% | −359.6% | — | — | — | — |
| Net margin | −283.1% | −328.6% | — | — | — | — |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +28.1% | — | — | — | — | — |
| Operating income growth | −10.3% | +35.7% | +24.1% | +22.7% | −26.3% | — |
| Net income growth | −10.4% | +36.4% | +43.0% | +1.2% | −109.8% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −33.1% | −24.7% | −31.3% | −68.4% | −94.3% | −39.1% |
| Return on assets | −30.2% | −23.4% | −28.5% | −37.5% | −29.7% | −12.8% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 7.0% | 5.8% | 5.3% | 13.5% | 233.2% | 206.2% |
| Net debt to equity | −86.1% | −84.8% | −93.5% | −100.0% | 6.4% | 170.2% |
| Current ratio | 2,306.3% | 3,285.8% | 4,129.1% | 970.8% | 137.8% | 12,895.4% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: MedPacto / 메드팩토 / 235980 / KRX:235980
Source: KRX statistical information